Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| HOME DEPOT, INC.HD · Entity 2816 | Director | May 18, 2017 | May 22, 2017 |
| L3HARRIS TECHNOLOGIES, INC. /DE/HRS · Entity 610 | Director | October 01, 2016 | October 04, 2016 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
HOME DEPOT, INC.
Report date May 18, 2017 · Filed May 22, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Deferred SharesSEC Table II · derivative / convertible security | Direct | 65,950.8062 |
Reported balance
After 2017-05-18 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2017-05-18 · Grant · Acquired 1,477.1997 · Balance 65,950.8062 F1: The Deferred Shares were granted under The Home Depot, Inc. Amended and Restated 2005 Omnibus Stock Incentive Plan and convert to shares of Common Stock on a one-for-one basis upon the earliest of (i) the first anniversary of the director's termination of service as a Board member, (ii) the date of the director's death, retirement or disability, or (iii) the date of a change in control of the Company. |
Filing footnotes · ownership attribution and instrument terms
F1: The Deferred Shares were granted under The Home Depot, Inc. Amended and Restated 2005 Omnibus Stock Incentive Plan and convert to shares of Common Stock on a one-for-one basis upon the earliest of (i) the first anniversary of the director's termination of service as a Board member, (ii) the date of the director's death, retirement or disability, or (iii) the date of a change in control of the Company.
L3HARRIS TECHNOLOGIES, INC. /DE/
Report date October 01, 2016 · Filed October 04, 2016
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Phantom Stock UnitsSEC Table II · derivative / convertible security | Direct | 88,228.58 |
Reported balance
After 2016-10-01 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2016-10-01 · Grant · Acquired 368.41 · Balance 88,228.58 F1: Each phantom stock unit is the economic equivalent of one share of the Issuer's common stock. F2: The phantom stock units were awarded on October 1, 2016 pursuant to an automatic quarterly grant under the Harris Corporation 2005 Directors' Deferred Compensation Plan. The phantom stock units are to be settled in cash upon the reporting person's retirement or other events. The reporting person may also transfer the phantom stock units into alternative investment accounts in certain other instances if applicable ownership guidelines are satisfied. F3: The aggregate of 88,228.58 phantom stock units includes: (a) 1,594.56 phantom stock units acquired through dividend reinvestment in the Harris Corporation Directors' Deferred Compensation Plans ("Plans") from 3/8/16 through 9/7/16 and (b) a reduction of a .19 phantom stock unit due to rounding of previous reports by the Plans' record keeper. |
Filing footnotes · ownership attribution and instrument terms
F1: Each phantom stock unit is the economic equivalent of one share of the Issuer's common stock.
F2: The phantom stock units were awarded on October 1, 2016 pursuant to an automatic quarterly grant under the Harris Corporation 2005 Directors' Deferred Compensation Plan. The phantom stock units are to be settled in cash upon the reporting person's retirement or other events. The reporting person may also transfer the phantom stock units into alternative investment accounts in certain other instances if applicable ownership guidelines are satisfied.
F3: The aggregate of 88,228.58 phantom stock units includes: (a) 1,594.56 phantom stock units acquired through dividend reinvestment in the Harris Corporation Directors' Deferred Compensation Plans ("Plans") from 3/8/16 through 9/7/16 and (b) a reduction of a .19 phantom stock unit due to rounding of previous reports by the Plans' record keeper.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
IMS Health Holdings, Inc.
Report date October 03, 2016 · Filed October 03, 2016
Section 16 reporting ended · disclosed 2016-10-03. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2016-10-03 transaction · row 1
1 source rowRow 1 · 2016-10-03 · Disposition to issuer · Disposed 11,633 · Balance 0 F1: On May 3, 2016, the issuer and Quintiles Transnational Holdings, Inc. ("Quintiles") entered into an Agreement and Plan of Merger pursuant to which on October 3, 2016 the issuer merged with and into Quintiles (the "merger"), the separate existence of the issuer ceased and Quintiles will continue as the surviving corporation, operating under the name Quintiles IMS Holdings, Inc. F2: Disposed of pursuant to merger agreement in exchange for 4,467 shares of Quintiles IMS Holdings, Inc. stock having a market value of $81.06 per share at the effective time of the merger. |
Filing footnotes · ownership attribution and instrument terms
F1: On May 3, 2016, the issuer and Quintiles Transnational Holdings, Inc. ("Quintiles") entered into an Agreement and Plan of Merger pursuant to which on October 3, 2016 the issuer merged with and into Quintiles (the "merger"), the separate existence of the issuer ceased and Quintiles will continue as the surviving corporation, operating under the name Quintiles IMS Holdings, Inc.
F2: Disposed of pursuant to merger agreement in exchange for 4,467 shares of Quintiles IMS Holdings, Inc. stock having a market value of $81.06 per share at the effective time of the merger.
PFIZER INC
Report date August 15, 2006 · Filed August 17, 2006
Section 16 reporting ended · disclosed 2006-08-17. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Phantom Stock Units SSPSEC Table II · derivative / convertible security | Direct | 39,665 |
Reported balance
After 2006-08-15 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2006-08-15 · Grant · Acquired 444 · Balance 39,665 F1: Each unit represents one phantom share of common stock. F2: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. |
Filing footnotes · ownership attribution and instrument terms
F1: Each unit represents one phantom share of common stock.
F2: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 14, 2005 Filed Nov 15, 2005 21:47 UTC | PFIZER INC PFE · Entity 2863 | GiftCommon Stock | 823 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-05-000279 · kat1066.xml · nonDerivative · entry 1 KATEN KAREN L · CIK 0001174451 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 756,151 Read SEC document |
| November 01, 2005 Filed Nov 2, 2005 21:52 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 108 | $21.55 Strike: $0.00 | $2,327.40 |
DisclosureSEC source: 0000078003-05-000265 · kat1058.xml · derivative · entry 1 KATEN KAREN L · CIK 0001174451 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,301 Underlying: Common Stock · 108 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| October 14, 2005 Filed Oct 18, 2005 19:03 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 87 | $24.32 Strike: $0.00 | $2,115.84 |
DisclosureSEC source: 0000078003-05-000255 · kat1048.xml · derivative · entry 1 KATEN KAREN L · CIK 0001174451 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,193 Underlying: Common Stock · 87 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| September 30, 2005 Filed Oct 3, 2005 21:15 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 89 | $24.97 Strike: $0.00 | $2,222.33 |
DisclosureSEC source: 0000078003-05-000243 · kat1036.xml · derivative · entry 1 KATEN KAREN L · CIK 0001174451 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,106 Underlying: Common Stock · 89 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| September 15, 2005 Filed Sep 16, 2005 15:23 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 86 | $25.70 Strike: $0.00 | $2,210.20 |
DisclosureSEC source: 0000078003-05-000235 · kat1028.xml · derivative · entry 1 KATEN KAREN L · CIK 0001174451 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,017 Underlying: Common Stock · 86 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| August 31, 2005 Filed Sep 2, 2005 15:52 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 93 | $25.47 Strike: $0.00 | $2,368.71 |
DisclosureSEC source: 0000078003-05-000226 · kat1017.xml · derivative · entry 1 KATEN KAREN L · CIK 0001174451 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,931 Underlying: Common Stock · 93 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| August 15, 2005 Filed Aug 16, 2005 20:19 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 326 | $26.20 Strike: $0.00 | $8,541.20 |
DisclosureSEC source: 0000078003-05-000217 · kat1008.xml · derivative · entry 1 KATEN KAREN L · CIK 0001174451 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,838 Underlying: Common Stock · 326 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| July 29, 2005 Filed Aug 1, 2005 19:52 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 86 | $26.50 Strike: $0.00 | $2,279.00 |
DisclosureSEC source: 0000078003-05-000206 · kat1000.xml · derivative · entry 1 KATEN KAREN L · CIK 0001174451 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,512 Underlying: Common Stock · 86 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| July 15, 2005 Filed Jul 19, 2005 13:54 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 84 | $27.57 Strike: $0.00 | $2,315.88 |
DisclosureSEC source: 0000078003-05-000192 · kat992.xml · derivative · entry 1 KATEN KAREN L · CIK 0001174451 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,426 Underlying: Common Stock · 84 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| June 30, 2005 Filed Jul 1, 2005 18:52 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 81 | $27.58 Strike: $0.00 | $2,233.98 |
DisclosureSEC source: 0000078003-05-000182 · kat979.xml · derivative · entry 1 KATEN KAREN L · CIK 0001174451 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,342 Underlying: Common Stock · 81 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| June 15, 2005 Filed Jun 17, 2005 12:15 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 75 | $28.43 Strike: $0.00 | $2,132.25 |
DisclosureSEC source: 0000078003-05-000154 · kat971.xml · derivative · entry 1 KATEN KAREN L · CIK 0001174451 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,261 Underlying: Common Stock · 75 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| May 31, 2005 Filed Jun 1, 2005 17:33 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 79 | $27.90 Strike: $0.00 | $2,204.10 |
DisclosureSEC source: 0000078003-05-000142 · kat963.xml · derivative · entry 1 KATEN KAREN L · CIK 0001174451 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,186 Underlying: Common Stock · 79 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| May 13, 2005 Filed May 16, 2005 17:38 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 299 | $27.86 Strike: $0.00 | $8,330.14 |
DisclosureSEC source: 0000078003-05-000133 · kat954.xml · derivative · entry 1 KATEN KAREN L · CIK 0001174451 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,107 Underlying: Common Stock · 299 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| May 10, 2005 Filed May 11, 2005 14:46 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 59,100 | $27.78 | $1,641,798.00 |
DisclosureSEC source: 0000078003-05-000129 · kat950.xml · nonDerivative · entry 2 KATEN KAREN L · CIK 0001174451 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 748,778 Read SEC document |
| May 10, 2005 Filed May 11, 2005 14:46 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 8,045 | $27.79 | $223,570.55 |
DisclosureSEC source: 0000078003-05-000129 · kat950.xml · nonDerivative · entry 1 KATEN KAREN L · CIK 0001174451 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 807,878 Read SEC document |
| April 29, 2005 Filed May 3, 2005 18:56 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 83 | $27.17 Strike: $0.00 | $2,255.11 |
DisclosureSEC source: 0000078003-05-000116 · kat941.xml · derivative · entry 1 KATEN KAREN L · CIK 0001174451 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,808 Underlying: Common Stock · 83 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| April 15, 2005 Filed Apr 19, 2005 15:03 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 74 | $27.71 Strike: $0.00 | $2,050.54 |
DisclosureSEC source: 0000078003-05-000093 · kat919.xml · derivative · entry 1 KATEN KAREN L · CIK 0001174451 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,725 Underlying: Common Stock · 74 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| March 31, 2005 Filed Apr 1, 2005 16:48 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 83 | $26.27 Strike: $0.00 | $2,180.41 |
DisclosureSEC source: 0000078003-05-000080 · kat905.xml · derivative · entry 1 KATEN KAREN L · CIK 0001174451 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,651 Underlying: Common Stock · 83 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| March 15, 2005 Filed Mar 16, 2005 20:06 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 83 | $26.29 Strike: $0.00 | $2,182.07 |
DisclosureSEC source: 0000078003-05-000073 · kat896.xml · derivative · entry 1 KATEN KAREN L · CIK 0001174451 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,568 Underlying: Common Stock · 83 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| March 11, 2005 Filed Mar 15, 2005 15:54 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 2,141 | $26.36 Strike: $0.00 | $56,436.76 |
DisclosureSEC source: 0000078003-05-000064 · kat887.xml · derivative · entry 1 KATEN KAREN L · CIK 0001174451 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,485 Underlying: Common Stock · 2,141 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| February 24, 2005 Filed Feb 28, 2005 20:09 UTC | PFIZER INC PFE · Entity 2863 | GrantEmployee Stock Option (right to buy) · Derivative | 371,000 | $0.00 Strike: $26.20 | $0.00 |
DisclosureSEC source: 0000078003-05-000046 · kat875.xml · derivative · entry 4 KATEN KAREN L · CIK 0001174451 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 371,000 Underlying: Common Stock · 371,000 shares Expires 2015-02-26 F2 · derivative.exercise_date: This option becomes exercisable in 3 equal annual installments beginning on February 24, 2008. Read SEC document |
| February 24, 2005 Filed Feb 28, 2005 20:09 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 58,135 | $26.20 | $1,523,137.00 |
DisclosureSEC source: 0000078003-05-000046 · kat875.xml · nonDerivative · entry 2 KATEN KAREN L · CIK 0001174451 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 811,879 Read SEC document |
| February 24, 2005 Filed Feb 28, 2005 20:09 UTC | PFIZER INC PFE · Entity 2863 | GrantCommon Stock | 125,280 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-05-000046 · kat875.xml · nonDerivative · entry 1 KATEN KAREN L · CIK 0001174451 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 870,014 F1 · shares: The reported transaction constitutes the earn-out of Performance-Contingent Shares. Read SEC document |
| December 31, 2004 Filed Jan 4, 2005 19:18 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 91 | $26.89 Strike: $0.00 | $2,446.99 |
DisclosureSEC source: 0000078003-05-000007 · kat851.xml · derivative · entry 1 KATEN KAREN L · CIK 0001174451 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,126 Underlying: Common Stock · 91 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| December 15, 2004 Filed Dec 17, 2004 19:08 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 64 | $28.32 Strike: $0.00 | $1,812.48 |
DisclosureSEC source: 0000078003-04-000377 · kat840.xml · derivative · entry 1 KATEN KAREN L · CIK 0001174451 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,035 Underlying: Common Stock · 64 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| November 30, 2004 Filed Dec 2, 2004 14:37 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 77 | $27.77 Strike: $0.00 | $2,138.29 |
DisclosureSEC source: 0000078003-04-000357 · kat828.xml · derivative · entry 1 KATEN KAREN L · CIK 0001174451 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,971 Underlying: Common Stock · 77 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| November 15, 2004 Filed Nov 17, 2004 18:39 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 272 | $27.62 Strike: $0.00 | $7,512.64 |
DisclosureSEC source: 0000078003-04-000343 · kat815.xml · derivative · entry 1 KATEN KAREN L · CIK 0001174451 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,894 Underlying: Common Stock · 272 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| November 05, 2004 Filed Nov 5, 2004 20:46 UTC | PFIZER INC PFE · Entity 2863 | GiftCommon Stock | 536 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-04-000335 · kat810.xml · nonDerivative · entry 1 KATEN KAREN L · CIK 0001174451 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 741,275 Read SEC document |
| October 29, 2004 Filed Nov 2, 2004 15:53 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 74 | $28.95 Strike: $0.00 | $2,142.30 |
DisclosureSEC source: 0000078003-04-000325 · kat803.xml · derivative · entry 1 KATEN KAREN L · CIK 0001174451 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,622 Underlying: Common Stock · 74 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| October 15, 2004 Filed Oct 19, 2004 13:48 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 79 | $28.50 Strike: $0.00 | $2,251.50 |
DisclosureSEC source: 0000078003-04-000314 · kat793.xml · derivative · entry 1 KATEN KAREN L · CIK 0001174451 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,548 Underlying: Common Stock · 79 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| September 30, 2004 Filed Oct 4, 2004 13:00 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 75 | $30.60 Strike: $0.00 | $2,295.00 |
DisclosureSEC source: 0000078003-04-000300 · kat783.xml · derivative · entry 1 KATEN KAREN L · CIK 0001174451 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,469 Underlying: Common Stock · 75 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| September 15, 2004 Filed Sep 17, 2004 14:24 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 70 | $31.85 Strike: $0.00 | $2,229.50 |
DisclosureSEC source: 0000078003-04-000274 · kat764.xml · derivative · entry 1 KATEN KAREN L · CIK 0001174451 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,394 Underlying: Common Stock · 70 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| August 31, 2004 Filed Sep 1, 2004 17:19 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 60 | $32.67 Strike: $0.00 | $1,960.20 |
DisclosureSEC source: 0000078003-04-000261 · kat754.xml · derivative · entry 1 KATEN KAREN L · CIK 0001174451 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,324 Underlying: Common Stock · 60 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| August 13, 2004 Filed Aug 17, 2004 17:17 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 227 | $31.15 Strike: $0.00 | $7,071.05 |
DisclosureSEC source: 0000078003-04-000247 · kat744.xml · derivative · entry 1 KATEN KAREN L · CIK 0001174451 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,264 Underlying: Common Stock · 227 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| July 30, 2004 Filed Aug 2, 2004 19:13 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 70 | $31.96 Strike: $0.00 | $2,237.20 |
DisclosureSEC source: 0000078003-04-000233 · kat734.xml · derivative · entry 1 KATEN KAREN L · CIK 0001174451 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,037 Underlying: Common Stock · 70 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| July 15, 2004 Filed Jul 19, 2004 15:41 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 68 | $32.58 Strike: $0.00 | $2,215.44 |
DisclosureSEC source: 0000078003-04-000215 · kat723.xml · derivative · entry 1 KATEN KAREN L · CIK 0001174451 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,967 Underlying: Common Stock · 68 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| June 30, 2004 Filed Jul 1, 2004 17:47 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 66 | $34.28 Strike: $0.00 | $2,262.48 |
DisclosureSEC source: 0000078003-04-000203 · kat713.xml · derivative · entry 1 KATEN KAREN L · CIK 0001174451 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,899 Underlying: Common Stock · 66 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| June 15, 2004 Filed Jun 16, 2004 19:42 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 61 | $35.09 Strike: $0.00 | $2,140.49 |
DisclosureSEC source: 0000078003-04-000171 · kat694.xml · derivative · entry 1 KATEN KAREN L · CIK 0001174451 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,833 Underlying: Common Stock · 61 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| May 28, 2004 Filed Jun 2, 2004 15:15 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 65 | $35.34 Strike: $0.00 | $2,297.10 |
DisclosureSEC source: 0000078003-04-000156 · kat681.xml · derivative · entry 1 KATEN KAREN L · CIK 0001174451 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,772 Underlying: Common Stock · 65 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| May 14, 2004 Filed May 18, 2004 14:17 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 197 | $35.60 Strike: $0.00 | $7,013.20 |
DisclosureSEC source: 0000078003-04-000138 · kat665.xml · derivative · entry 1 KATEN KAREN L · CIK 0001174451 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,707 Underlying: Common Stock · 197 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| April 30, 2004 Filed May 4, 2004 16:40 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 63 | $35.76 Strike: $0.00 | $2,252.88 |
DisclosureSEC source: 0000078003-04-000117 · kat654.xml · derivative · entry 1 KATEN KAREN L · CIK 0001174451 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,510 Underlying: Common Stock · 63 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| April 15, 2004 Filed Apr 19, 2004 15:21 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 61 | $37.34 Strike: $0.00 | $2,277.74 |
DisclosureSEC source: 0000078003-04-000091 · kat629.xml · derivative · entry 1 KATEN KAREN L · CIK 0001174451 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,447 Underlying: Common Stock · 61 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| March 31, 2004 Filed Apr 2, 2004 18:09 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 57 | $35.05 Strike: $0.00 | $1,997.85 |
DisclosureSEC source: 0000078003-04-000079 · kat620.xml · derivative · entry 1 KATEN KAREN L · CIK 0001174451 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,386 Underlying: Common Stock · 57 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| March 25, 2004 Filed Mar 26, 2004 18:46 UTC | PFIZER INC PFE · Entity 2863 | GrantCommon Stock | 67,800 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-04-000061 · kat603.xml · nonDerivative · entry 1 KATEN KAREN L · CIK 0001174451 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 736,106 F1 · shares: The reported transaction constitutes the grant of restricted stock. Read SEC document |
| March 15, 2004 Filed Mar 16, 2004 18:02 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 11 | $34.95 Strike: $0.00 | $384.45 |
DisclosureSEC source: 0000078003-04-000051 · kat594.xml · derivative · entry 2 KATEN KAREN L · CIK 0001174451 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,329 Underlying: Common Stock · 11 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| March 12, 2004 Filed Mar 16, 2004 18:02 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 1,828 | $35.29 Strike: $0.00 | $64,510.12 |
DisclosureSEC source: 0000078003-04-000051 · kat594.xml · derivative · entry 1 KATEN KAREN L · CIK 0001174451 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,318 Underlying: Common Stock · 1,828 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| February 26, 2004 Filed Mar 1, 2004 20:45 UTC | PFIZER INC PFE · Entity 2863 | GrantEmployee Stock Option (right to buy) · Derivative | 350,000 | $0.00 Strike: $37.15 | $0.00 |
DisclosureSEC source: 0000078003-04-000037 · kat577.xml · derivative · entry 4 KATEN KAREN L · CIK 0001174451 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 350,000 Underlying: Common Stock · 350,000 shares Expires 2014-02-26 F2 · derivative.exercise_date: This option becomes exercisable in three equal annual installments beginning on February 26, 2007. Read SEC document |
| February 26, 2004 Filed Mar 1, 2004 20:45 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 16,049 | $37.15 | $596,220.35 |
DisclosureSEC source: 0000078003-04-000037 · kat577.xml · nonDerivative · entry 2 KATEN KAREN L · CIK 0001174451 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 666,097 Read SEC document |
| February 26, 2004 Filed Mar 1, 2004 20:45 UTC | PFIZER INC PFE · Entity 2863 | GrantCommon Stock | 40,680 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-04-000037 · kat577.xml · nonDerivative · entry 1 KATEN KAREN L · CIK 0001174451 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 682,146 F1 · shares: The reported transaction constitutes the earn-out of Performance-Contingent Shares. Read SEC document |
| December 31, 2003 Filed Jan 5, 2004 16:44 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 58 | $35.33 | $2,049.14 |
DisclosureSEC source: 0000078003-04-000005 · kat547.xml · derivative · entry 1 KATEN KAREN L · CIK 0001174451 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,372 Underlying: Common Stock · 58 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.